Registered outcomes14

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 14 of 14

List	Outcome	Time frame	Description
Primary	Proportion of Successful Contacts	2 weeks after enrollment	The number of successful contacts will be divided by the total number of contacts. A "successful" contact is when an enrolled patient answered the phone, and consented to the research assistant administering the questionnaire(s) planned for that phone call.
Primary	Median Number of Attempts Required to Achieve a Successful Contact	2 weeks after enrollment	This is the median number of call attempts made until a research assistant is able to successfully administer the questionnaire(s) planned for that phone call.
Primary	Median Cost Associated With Personnel Time	At the end of the study (2 weeks after the 2-year intervention phase (extended due to COVID))	This measure is median monthly costs incurred to pay the research assistant for the time s/he spends making the required phone calls per patient.
Primary	Median Cost Associated With Telephone Time	At the end of the study (2 weeks after the 2-year intervention phase (extended due to COVID))	This measure is the median costs incurred to make phone calls per patient in each study phase.
Primary	Telephone Triage Tool Administration Time	After administration of the telephone triage tool (i.e. about 2 weeks after enrollment)	This measure will be calculated based on how much time it takes to administer the telephone triage tool.
Primary	Physician Assessment of Whether a Patient Would Benefit From Further Services	Immediately after the physician administers the physical exam (i.e. about 3 weeks after enrollment)	This is a binary measure. After a physician examines a participant, s/he will determine whether s/he thinks the participant would benefit from further services (including additional follow-up care, and/or diagnostic or therapeutic interventions).
Primary	Physician Assessment of Whether a Patient Was at Moderate to High Risk for a Poor Outcome (HR) Without Additional Intervention	Immediately after the physician administers the physical exam (i.e. about 3 weeks after enrollment)	After a physician examines a participant, s/he will determine whether s/he thinks the participant is at low, moderate or high risk for a poor outcome (HR) without additional intervention using subjective clinical assessment.
Primary	Triage Risk Score (TRS)	At the end of intervention phase (about 1 year after enrollment).	To develop a sensitive model capable of risk stratifying triaged patients for high risk (HR), all candidate questions from the telephone triage tool found to associate with HR on univariate regression were weighted by their predictive coefficient and added to generate a triage risk score (TRS) ranging from a minimum score of 0 (lowest risk) to a maximum possible score of 43.9 (highest risk). Triage Risk Score (TRS) less than or equal to 1.3 (1st quartile) was designated as low risk, TRS 1.4 to 4.0 (2nd \& 3rd quartile) as moderate risk, and TRS greater than or equal to 4.1 (fourth quartile) as high risk.
Primary	Acceptability Score of Mobile Phones as a Follow-up Tool	2 weeks after enrollment	This is a numerical measure that represents the sum of the positive responses that participants give to each question that assesses the acceptability of mobile phones as a follow-up tool. The scale for the acceptability score of mobile phones as a follow-up tool ranges from 0 to 6, where 0 means the participant's responses indicate the participant believes mobile phones are definitely not an acceptable follow-up tool and 6 means the participant's responses indicate the participant believes mobile phones are definitely an acceptable follow-up tool.
Primary	Proportion of Injured Patients Who Seek Clinical Follow-up Evaluation	After the 2week post-discharge phonecall.	This will be calculated as follows: The denominator will be the number of discharged trauma patients enrolled in the study. The numerator will be the number of discharged trauma patients enrolled in the study who seek any clinical follow-up evaluation at the 2 weeks post-discharge phonecall.
Secondary	Glasgow Outcomes Scale-Extended (GOSE) Disability Level	At the 2week post-discharge telephone phonecall.	The GOSE disability level that participants in the study report. For each participant, GOSE disability level will be determined using the augmented GOSE (aGOSE) instrument, which assesses factors like the participant's independence inside and outside the home, work, social and leisure activities, family and friendship, etc. Each time after administration of the aGOSE instrument, the participant's GOSE disability level will be calculated. The aGOSE score is reported for the 2-week post-discharge timepoint. The Glasgow Outcome Scale (GOS) is a global scale for functional outcome that rates patient status into one of five categories (worse to best respectively): Dead, Vegetative State, Severe Disability, Moderate Disability or Good Recovery. The Extended GOS (GOSE) which was used in this study provides more detailed categorization into eight categories by subdividing the categories of severe disability, moderate disability and good recovery into a lower and upper category.
Secondary	Economic Consequences of Injury: Did it Become More Difficult for the Family to Afford Expenses Such as Food and Rent?	At the 2week post-discharge telephone phonecall.	Participants were asked if following the injury it became more difficult for the family to afford expenses such as food and rent.
Secondary	Economic Consequences of Injury: Did the Family Spend Saved Money?	At the 2week post-discharge telephone phonecall.	Participants were asked if following the injury the family had to spend their savings.
Secondary	Economic Consequences of Injury: Did the Family Borrow Money?	At the 2week post-discharge telephone phonecall.	Participants were asked if following the injury the family had to borrow money to meet up with expenses.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03805646/registered

API reference For AI assistants